New Drug Safety Podcasts - Drug Information Update

The Division of Drug Information (DDI) - serving the public by providing information on human drug products and drug product regulation by FDA

FDA’s Division of Drug Information has posted new Drug Safety Podcasts. Click on the following links to listen to podcasts and read the transcripts.

FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings

FDA review finds no significant increase in risk of serious asthma outcomes with long-acting beta agonists (LABAs) used in combination with inhaled corticosteroids (ICS)

You can download other Drug Safety Podcasts at:  FDA Drug Safety Podcasts or subscribe to the Drug Safety Podcasts channel in iTunes at: Drug Safety Podcasts.